Acceptability and Feasibility of an ACT-Based Group to Improve Diabetes Self-Management
NCT ID: NCT02256293
Last Updated: 2015-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE1/PHASE2
INTERVENTIONAL
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acceptance and Commitment Therapy Principles for Diabetes Prevention
NCT05260983
ACT Stress Management in Type 1 Diabetes
NCT02914496
Acceptance and Value Based Methods in Increasing Wellbeing of Adolescents With Type 1 Diabetes
NCT03825562
An ACT Based Application for Young People With Type 1 Diabetes
NCT02526069
Impact of ACT-based Interventions on Diabetes-related Outcomes
NCT04028427
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group Therapy
Diabetes self-management group based on Acceptance and Commitment Therapy (ACT).
Diabetes self-management group based on Acceptance and Commitment Therapy (ACT).
The group sessions will be lead by a clinician trained in Acceptance and Commitment Therapy and will meet at Duke Medical Center for 1 ½ hours once a week for a total of 8 weeks. During group sessions, participants will identify how avoidance of difficult thoughts and feelings about diabetes has interfered with diabetes management and learn alternative ways of coping with these experiences. The group sessions are intended to supplement regular medical treatment; thus it is important that subjects continue to have diabetes symptoms monitored by their current treatment provider.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diabetes self-management group based on Acceptance and Commitment Therapy (ACT).
The group sessions will be lead by a clinician trained in Acceptance and Commitment Therapy and will meet at Duke Medical Center for 1 ½ hours once a week for a total of 8 weeks. During group sessions, participants will identify how avoidance of difficult thoughts and feelings about diabetes has interfered with diabetes management and learn alternative ways of coping with these experiences. The group sessions are intended to supplement regular medical treatment; thus it is important that subjects continue to have diabetes symptoms monitored by their current treatment provider.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with type 1 diabetes
* Currently monitored by a physician for their diabetes
Exclusion Criteria
* Current substance abuse
* Non-English Speaking
* Deficits in intellectual functioning that preclude informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rhonda Merwin, PhD
Role: PRINCIPAL_INVESTIGATOR
Duke University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00040489
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.